The resistance status in Hyalomma ticks collected from animal farms in three different regions of the Emirate of Abu Dhabi (UAE) was estimated using adult immersion tests with various concentrations of cypermethrin (50ppm, 100 ppm, 200 ppm, 400ppm and 800 ppm). Regression graphs of tick mortality plotted against cypermethrin concentrations were utilized to determine lethal concentrations (LC50 and LC90). The data generated on different life history variables (mortality, egg mass weight, reproductive index, and percent inhibition of oviposition) were used to assess the resistance status. Results revealed level III cypermethrin resistance in Hyalomma anatolicum of the Al Hamam region (Al Ain) and level II resistance in the Malaqet region (Al Ain), whereas level I resistance was observed in the other studied locations, except Sweihan (Al Ain) where the tick population was fully susceptible. The LC90 value of susceptible (Sweihan) H. anatolicum was 244.87ppm and the discriminating dose (DC) was calculated to be 489.74ppm. The present study is the first report of cypermethrin resistance in ticks of the United Arab Emirates and highlights the need to further monitor resistance evolution during the implementation of tick control programs.

Background: Infectious Bronchitis (IB), caused by the infectious bronchitis virus (IBV), is a significant contagious respiratory disease in the poultry industry. The emergence of new variants represents a global challenge for the diagnosis and control of the disease. Despite vaccination efforts in poultry farms in the Abu Dhabi Emirate, United Arab Emirates (UAE), outbreaks continue to occur, raising concerns about the efficacy of vaccination protocols and the potential emergence of new viral strains. This study aims to provide information on clinical, pathological, and genotypes of IBV detected within the Abu Dhabi Emirate, during 2022–2023.Methods: Epidemiological data were collected from twelve suspected IB outbreaks across seven broiler farms located in the Abu Dhabi Emirate. The cases were investigated through clinical and pathological examinations and Forty-six samples, including lung, spleen, kidney tissues, and oro-cloacal swabs, were collected for further analysis. The virus was detected by RT-qPCR assay, genotyping was determined by phylogenetic analysis of the Spike (S)-1 gene, and differentiation between field and vaccine strains was determined by comparing their sequences.Results: The age of the affected flocks varies from 2 to 5 weeks. The highest morbidity, mortality and case fatality rates were 36, 33, and 95%, respectively. Necropsy examination revealed characteristic respiratory and renal pathological lesions. Phylogenetic analysis revealed a co-circulation of three lineages of IBV genotype GI-13 or 4/91 serotype (81.8%), GI-1 or Massachusetts serotype (9.1%) and GI-23 or Middle East serotype (9.1%). Approximately 90.9% of the strains classified within GI-1 and G1-13 lineages are 99 to 100% identical to 4/91 and Mass serotypes, respectively, and are considered as vaccine strains. Two strains (9.1%) classified within GI-23 lineage have a < 99% identity to the 4/91 and Mass serotypes vaccine strains and are considered as filed strains.Conclusion: Co-circulation of three IBV lineages (GI-13, GI-1, and GI-23) in the Abu Dhabi broiler flocks showing IB symptoms were detected. This complex scenario of different IBV lineages circulation may account for the persistent outbreaks despite vaccination efforts. The results of the study are crucial for optimum IB vaccination and monitoring strategies or designing new vaccines based on local IBV field strains.

Background: Peste des petits ruminants (PPR) is an acute or subacute contagious trans-boundary viral disease causing high morbidity and mortality in domestic and wild small ruminants. The national UAE-PPR control and eradication plan follows the PPR Global Control and Eradication Strategy (PPR GCES) and relies on the annual mass vaccination of small ruminants to eradicate the disease from the country by 2030. Despite the immunization effort against PPR, the vaccination coverage reached 65% at maximum, which necessitates conducting a post-vaccination evaluation (PVE) study at the national level. Methods: Using multistage random sampling to assess the PPR vaccine and vaccination effectiveness, protocol (2) of the PPR GCES, using two serosurveys; serosurvey (1) (pre-vaccination) at day 0 before vaccination, to assess the primary PPR serological investigation, and serosurvey (2) at (30–90) days post-PPR vaccination, to evaluate the immune response, were carried out from September to December 2024 across the seven Emirates of the UAE. The nucleoprotein-based competitive enzyme-linked immunosorbent assay (c-ELISA) was used to detect PPR antibodies in a total of 1592 and 1589 sera samples collected, respectively, before and after vaccination from different (n = 163) sheep and goats holdings (epi-unit) distributed in the different Emirates of the UAE. Results: In serosurvey (1). prior to vaccination, out of the total 1592 samples tested (839 goats and 753 sheep), 833 animals (52.32%) were found to be seropositive for PPR antibodies. In contrast, in serosurvey (2), after vaccination, 1490 (93.77%) animals were found to be seropositive out of the total 1589 small ruminants (825 goats and 764 sheep) tested by c-ELISA. A statistically significant increase (41.45%) in the overall seroprevalence from (52.32%) pre-vaccination to (93.77%) post-vaccination was observed. Post-vaccination, 93.87% (n = 153) of the vaccinated epi-units achieved more than 70% seroprevalence compared to 43.56% (n = 71) before vaccination. Prediction analysis showed that all the seven UAE Emirates require 1.2 years maximum to reach 100% immune-protection levels. Conclusions: An efficient PPR vaccine was used to immunize small ruminants in the UAE. Higher (89.47–100%) post-vaccination herd immunity than the threshold recommended by the PPR GCES (>80% immunity) was attained, which can efficiently break the spread of PPRV within the UAE. To enhance the eradication of PPR I the UAE, conducting mass vaccination campaigns targeting over the (95%) immunization coverage of eligible animals for the next three years is recommended to attain the requested sustained (>80%) immunity at the animals holding level.